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The	emergence	of	new	pathogens	and	the	increasing	drug-resistance	of	recognized	ones	pose	a	difficult	challenge.	One	way	
that	this	challenge	is	being	addressed	is	through	the	discovery	of	new	cost-effective	drug	resources	in	the	form	of	bioactive	
compounds.	Algae	represent	a	promising	source	of	bioactive	compounds	in	this	regard.	In	the	present	research,	we	used	
molecular	and	phylogenetic	analysis	to	isolate	and	identify	two	microalgal	strains.	We	found	that	one	strain	belonged	to	the	
phylum	chrysophyta	and	the	other	to	the	cyanobacteria.	We	also	investigated	the	antimicrobial	activity	of	some	of	the	lipophilic	
extracts	of	the	two	microalgal	strains.	Several	fractions	showed	high	individual	antimicrobial	bioactivity	against	multidrug-
resistant	Salmonella	sp.,	Citrobacter	sp.,	Aspergillus niger	and	Aspergillus flavus.	Fraction	III	from	Poterioochromonas 
malhamensis	showed	the	highest	level	of	activity	against	two	multidrug-resistant	bacterial	pathogens.	The	inhibition	zone	
diameter	was	1.4	cm	for	Salmonella	and	1.4	cm	for	Citrobacter.	Meanwhile,	another	lipophilic	fraction	from	the	cyanobacterium	
Synechocystis salina	showed	broad-spectrum	bioactivity	(inhibition	zone	diameter	of	0.9	cm	for	Aspergillus niger,	1	cm	for	
Citrobacter	and	0.9	cm	for	Salmonella).	One	lipophilic	fraction	from	Aphanizomenon	showed	antifungal	bioactivity	against	
Aspergillus niger	and	Aspergillus flavus,	where	the	inhibition	zone	diameter	was	1.1	cm	and	1.0	cm,	respectively.	The	study	
highlights	the	antimicrobial	bioactivity	of	extracts	from	local	microalgae	and	emphasizes	the	importance	of	carrying	out	
screening	programs	for	those	microorganisms.	
Keywords.	Antimicrobial,	Aphanizomenon,	Aspergillus,	Citrobacter,	multidrug-resistant,	Salmonella,	Poterioochromonas 
malhamensis, Egypt.
Caractérisation moléculaire de deux souches de micro-algues issues d’Égypte et recherche d’une activité antimicrobienne 
de leurs extraits. L’émergence	de	nouveaux	agents	pathogènes	et	l’augmentation	de	la	résistance	aux	médicaments	de	ceux	qui	
sont	connus	posent	un	défi	difficile.	Des	composés	bioactifs,	économiquement	rentables,	récemment	découverts,	sont	étudiés	à	
cette	fin.	Des	micro-algues	en	constituent	une	source	prometteuse.	Dans	le	présent	travail	de	recherche,	nous	avons	pu	isoler	et	
identifier	deux	souches	de	micro-algues	en	utilisant	l’analyse	moléculaire	et	phylogénétique	et	nous	montrons	qu’une	des	deux	
souches	appartient	aux	chrysophycées	et	l’autre	aux	cyanobactéries.	Nous	rapportons	également	une	activité	antimicrobienne	
de	certains	de	leurs	extraits	lipophiles.	Plusieurs	fractions	ont	montré	un	niveau	élevé	de	bioactivité	antimicrobienne	contre	
plusieurs	organismes	résistants	à	plusieurs	médicaments,	Salmonella	sp.,	Citrobacter	sp.,	Aspergillus niger	et	Aspergillus 
flavus.	La	fraction	3	de	Poterioochromonas malhamensis	a	montré	le	niveau	d’activité	le	plus	élevé	contre	deux	pathogènes	
bactériens	résistants	à	plusieurs	médicaments.	Le	diamètre	de	la	zone	d’inhibition	était	de	1,4	cm	pour	Salmonella	et	1,4	cm	
pour	Citrobacter.	Parallèlement,	une	autre	fraction	lipophile	de	la	cyanobactérie	Synechocystis salina	a	présenté	une	activité	
biologique	à	large	spectre	(le	diamètre	de	la	zone	d’inhibition	était	de	0,9	cm	pour	Aspergillus niger,	1	cm	pour	Citrobacter	et	
0,9	cm	pour	Salmonella).	Une	fraction	lipophile	d’Aphanizomenon	a	montré	une	bioactivité	antifongique	contre	Aspergillus 
niger et	Aspergillus flavus,	les	zones	d’inhibition	ayant	un	diamètre	de	1,1	cm	et	1,0	cm,	respectivement.	Cette	étude	met	
en	évidence	l’activité	antimicrobienne	de	micro-algues	locales	et	démontre	l’intérêt	de	la	mise	sur	pied	de	programmes	de	
dépistage	de	ces	micro-organismes.
Mots-clés.	 Antimicrobien,	 Aphanizomenon,	 Aspergillus,	 Citrobacter,	 résistance	 à	 plusieurs	 médicaments,	 Salmonella,	
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1. INTRODUCTION
Algae	 are	 oxygenic	 phototrophs	 found	 in	 all	 water	
bodies	 worldwide.	 They	 comprise	 different	 groups	
of	 organisms,	 varying	 widely	 in	 their	 morphology,	
anatomy	and	habitats	and	capable	of	surviving	in	the	
most	extreme	niches	(Whitton	et	al.,	2000).	Microalgae	
have	the	ability	to	produce	a	wide	range	of	bioactive	
compounds	(Thajuddin	et	al.,	2005),	enabling	them	to	
cope	with	their	environments	and	to	out-compete	other	
co-existing	microorganisms	through	the	antimicrobial	
effect	of	those	compounds	(Mundt	et	al.,	2003).	It	is	
well	known	that	the	current	sources	of	antimicrobial	
compounds	mostly	originate	from	actinomycetes	and	
plants	(Borowitzka,	1995).	We	are	currently	witnessing	
the	declining	effectiveness	of	widely	used	antibiotics	
and	the	emergence	of	new	pathogenic	microorganisms	
and/or	 the	 increasing	 resistance	 of	 existing	 ones	
(Skulberg,	 2000).	 This	 means	 that	 it	 is	 becoming	
increasingly	important	to	search	for	new	sources	of	
bioactive	 antimicrobial	 compounds.	 Cyanobacteria	
(blue-green	algae)	are	considered	to	be	a	rich	source	of	
secondary	metabolites	that	has	yet	to	be	fully	explored	
(Ehrenreich	 et	 al.,	 2005).	 According	 to	 Skulberg	
(2000),	 the	 pharmaceutical	 effects	 and	 modes	 of	
action	 of	 cyanobacterial	 secondary	 metabolites	 are	
diverse	 (Thajuddin	 et	 al.,	 2005).	These	 compounds	
include	 immunosuppressants	 and	 toxins,	 as	 well	 as	
antimicrobial	and	anti-tumor	compounds	(Ehrenreich	
et	al.,	 2005;	 Barrios-Llerena	 et	 al.,	 2007).	 The	
importance	of	cyanobacteria	as	a	potential	drug	resource	
is	 evidenced	 by	 the	 launch	 of	 the	 “Cyanomyces”	
project	 in	 Europe,	 which	 aims	 to	 generate	 novel	
therapeutic	 substances	 by	 combining	 genes	 from	
actinomycetes	 and	 cyanobacteria	 (http://www.
cyanomyces.com)	(Asthana	et	al.,	2006).	In	addition,	
other	microalgae	have	long	been	known	to	be	potent	
sources	of	antimicrobial	compounds	(see,	for	example,	
Pratt	et	al.,	1944	on	Chlorella;	Rossell	et	al.,	1987	on	
brown	algae).	Among	the	chrysophytes,	a	chlorophyll-
related	bioactive	compound	called	malhamensilipin	A	
has	 been	 isolated	 from	 Poterioochromonas	 (Pereira	
et	al.,	2010).	Porphyrin	forms	the	core	of	chlorophyll	
and	derivatives	of	this	lipophilic	compound	include	
(Z)-24-propylidenecholesterol,	which	is	proposed	as	
a	 chemotaxonomic	 marker	 for	 some	 chrysophytes	
belonging	to	the	class	Pelagophyceae	(Giner	et	al.,	
1998).	 Porphyrin	 derivatives	 have	 also	 been	 found	
in	dinoflagellates	and	are	thought	to	play	a	defensive	
role	whereby	their	structural	modifications	make	the	
sterols	 inedible	 to	 marine	 invertebrates,	 hindering	
predation	and	thereby	enhancing	the	bloom-forming	
ability	of	dinoflagellates	(Giner	et	al.,	2003).
In	Egypt,	local	strains	of	microalgae	are	proving	to	
represent	quite	promising	potent	sources	of	bioactive	
antimicrobial	 compounds	 (Issa,	 1999;	 El-Sheekh	
et	al.,	2006),	especially	lipophilic	microalgal	extracts	
(El	 Semary	 et	 al.,	 2009;	 El	 Semary	 et	 al.,	 2010;	
El	Semary,	2012).	Our	research	follows	on	from	these	
earlier	 studies	 by	 carrying	 out	 further	 screening	 of	
microalgae	 collected	 from	 the	 Helwan	 Governorate	
region	of	Egypt.	In	the	present	study,	two	microalgae	
were	 isolated,	 one	 belonging	 to	 the	 chrysophytes	
and	the	other	to	the	cyanobacteria.	First	of	all,	we	
established	the	taxonomic	identity	of	these	microalgae.	
We	then	investigated	the	antimicrobial	bioactivity	of	
lipophilic	extracts	taken	from	both	these	microalgae	
and	from	another	cyanobacterial	strain,	against	many	
pathogenic	microorganisms,	some	of	them	multidrug-
resistant	 strains.	 The	 lipophilic	 extracts	 from	 the	
microalgal	strains	were	then	fractionated	using	column	
chromatography	and	the	separated	fractions	were	used	
in	antimicrobial	bioassay.	
2. MATERIALS AND METHODS
2.1. Sampling and establishing microalgal cultures
Water	 samples	 were	 collected	 in	 sterile	 samplers	
from	 the	 River	 Nile,	 in	 the	 Maadi	 area,	 and	 from	
a	 wastewater	 canal,	 in	 Helwan	 Governorate.	
Microscopic	 examination	 revealed	 the	 presence	 of	
cyanobacteria,	 diatoms,	 chrysophytes	 and	 some	
chlorophytes.	Water	samples	were	spun	and	spread	on	
solid	Oscillatoria	medium	(Feuillade,	1994)	and	ASN	
medium	(50	ml	medium:	0.5	gm	agar,	v:	wt).	Colonies	
were	identified	using	light	microscopy,	and	were	then	
purified	and	used	to	establish	monospecific	cultures.	
Two	 microalgae	 were	 isolated:	 one	 a	 chrysophyte	
from	the	River	Nile	and	one	a	cyanobacterium	from	
Teraat	El	Khashaab.	The	two	cultures	were	purified	
and	identified	morphologically	using	light	microscopy.	
2.2. Taxonomic identification of the two 
microalgae
Genomic	 DNA	 was	 extracted	 using	 a	 modified	
method	from	Smoker	et	al.	(1988).	The	small	subunit	
rRNA	 gene	 was	 used	 as	 a	 taxonomic	 marker.	 For	
the	cyanobacterium,	the	purified	genomic	DNA	was	
used	 as	 a	 template	 for	 amplification	 of	 partial	 16S	
rDNA	 using	 cyanobacterial	 highly-specific	 primers	
Cya395	and	781R1,	2	(Nübel	et	al.,	1997).	Almost	the	
full	 length	 of	 16S	 rDNA	 was	 then	 obtained	 using	
the	Cya395	forward	primer	in	combination	with	the	
1492	reverse	primer	designed	by	Delong	(1992).	The	
taxonomic	identity	of	the	two	microalgae	was	verified	
using	Euk	forward	and	Euk	reverse	primers	(Delong,	
1992).	The	16S	rRNA	and	18S	rRNA	gene	sequences	
were	 deposited	 in	 the	 GenBank	 database	 under	 the	
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For	 the	 purpose	 of	 phylogenetic	 analyses,	
cyanobacterial	 16S	 rRNA	 gene	 sequences	 were	
imported	from	GenBank	and	aligned	in	the	Clustal	W	
tool	 within	 the	 alignment	 function	 of	 the	 MEGA4	
phylogenetic	 package.	 Similarly,	 the	 closely-related	
18S	 rRNA	 genetic	 sequences	 of	 Ochromonas	 were	
used	to	reconstruct	phylogenetic	trees	using	different	
methods	integrated	into	the	MEGA4	software	(Tamura	
et	al.,	2007).	Bootstrap	values	from	500	resamplings	
were	calculated	for	each	set	of	data	and	all	trees	were	
rooted	using	the	unicellular	cyanobacterium	Microcystis 
aeruginosa	 PCC7806	 for	 the	 cyanobacterium	 and	
Scenedesmus  communis	 for	 the	 Ochromonas.	 All	
resulting	 trees	 had	 similar	 topologies,	 indicating	
similar	phylogenetic	relationships.	The	bootstrapped-
consensus	maximum	parsimony	tree	was	chosen	for	
presentation.	 The	 ME	 tree	 was	 searched	 using	 the	
Close-Neighbor-Interchange	 (CNI)	 algorithm	 (Nei	
et al.,	2000).	The	Neighbor-Joining	algorithm	(Saitou	
et	 al.,	 1987)	 was	 used	 to	 generate	 the	 initial	 tree.	
Phylogenetic	analyses	were	conducted	using	MEGA4	
(Tamura	et	al.,	2007).
2.3. Antimicrobial bioassay
Initial  antibiotic  susceptibility  test.	 Pathogenic	
microbes	(Table 1)	were	used	as	test	microorganisms	
in	antimicrobial	tests	(Doan	et	al.,	2000).	These	test	
organisms	were	potent	microbial	pathogens	collected	
from	clinical	samples	and	preserved	as	pure	cultures.	
Their	 pathogenic	 effects	 are	 listed	 in	 table 1.	 The	
isolates	were	identified	using	traditional	biochemical	
tests	(Murray	et	al.,	1995).	The	tested	organisms	were	
subcultured	at	37	ºC	and	were	maintained	on	nutrient	
agar	 media	 (Oxide,	 UK).	 Several	 antibiotics	 were	
tested	in	the	initial	susceptibility/resistance	test.	The	
bacterial	 isolates	 were	 tested	 for	 their	 resistance	 to	
antibiotics	using	a	disk	diffusion	method	on	Mueller-
Hinton	agar	(Oxide,	UK)	and	were	incubated	overnight	
at	37	°C.	The	antibiotic	disks	(Oxoid,	UK)	used	were	
ampicillin	 (10	μg),	 cefepime	 (30	μg),	 cefotaxime	
(30	μg),	 chloramphenicol	 (30	µg),	 doxycycline	
(30	µg),	 erythromycin	 (15	µg),	 levofloxacin	 (5	µg),	
rifampicin	(30	µg),	tobramycin	(10	µg),	ciprofloxacin	
(15	µg),	amikacin	(30	µg)	amoxycillin/clavulinic	acid	
(30	µg),	 oxacillin	 (30	µg),	 and	 ceftriaxone	 (30	µg).	
Zones	 of	 inhibition	 were	 determined	 in	 accordance	
with	the	National	Committee	for	Clinical	Laboratory	
Standards	(NCCLS,	2000);	isolates	were	categorized	
as	either	susceptible	or	resistant	(Table 2).	Results	of	
the	antibiotic	susceptibility	test	are	recorded	in	table 2.
Antimicrobial  bioassay  of  lipophilic  extracts.	
Microalgal	biomass	(1	g	fresh	wt.)	was	collected	from	
both	microalgae	as	well	as	from	Aphanizomenon	sp.	
and	the	samples	were	then	lyophilized.	The	lyophilized	
cells	 were	 extracted	 twice	 with	 100	ml	 chloroform:	
methanol	(2:1,	v:	v)	HPLC	grade	for	two	days,	and	then	
centrifuged	(14,000	×	g)	for	30	min	using	a	Hettich-
cooling	 centrifuge	 (Germany).	 The	 supernatant	 was	
left	to	evaporate	to	dryness	and	was	then	re-dissolved	
in	 3	ml	 chloroform:	 methanol	 (2:1,	 v:	v)	 (modified	
from	Doan	et	al.,	2000).	The	sample	was	applied	to	a	
Silica	gel	G60	column	(1.5	x	25	cm)	prepared	from	the	
Table 1. List	of	microbial	pathogens	tested	—	Liste des pathogènes microbiens testés.
Microbial strain and author  Type Pathogenicity (diseases)
Escherichia coli	Migula	1895	 Gram	negative	 Gastrointestinal	and	urinary	tract	infection
Citrobacter	sp.	
Werkman	&	Gillen	1932
Gram	negative	 Bacteremia	associated	with	malignancies	
Salmonella typhi Schroeter	1886	 Gram	negative	 Salmonellosis	(food	poisoning)
Proteus mirabilis	Hauser	1885 Gram	negative	 Wound	infections,	septicemia	and	pneumonias
Staphylococcus epidermidis	
Winslow	and	Winslow	1908	
Gram	positive Infection	in	catheters	as	it	grows	as	biofilms	on	plastic	devices	
inserted	within	the	body
MRSA		Staphylococcus aureus	
Rosenbach	1884
Gram	positive Food	poisoning	and	infection	in	hospitals	(common	hospital	
bug)
Streptococccus faecalis	
Andrewes	&	Horder	1906	
Gram	positive	 Endocarditis,	as	well	as	bladder,	prostate,	and	epididymal	
infections
Klebsiella pneumoniae	
Schroeter	1886	
Gram	negative	 The	Klebsiella pneumonia	disease	(human	lungs	inflammation	
and	hemorrhage)
Pseudomonas aeruginosa	
Schroeter	1872	
Gram	negative	 Generalized	inflammation	and	sepsis
Aspergillus niger	Tiegh	1809 Filamentous	fungus Lung	disease	(aspergillosis)	
Aspergillus flavus Link	1809 Filamentous	fungus Aspergillosis	of	lungs	and	sometimes	otomycotic,	infectionsAntimicrobial	activity	of	extracts	from	microalgae	 315
slurry	from	30	g	of	precipitated	Silica	gel	G60	(Merck,	
UK).	The	lipophilic	fractions	were	collected	using	the	
solvent	system	shown	in	table 3.	
The	 lipophilic	 extracts	 were	 concentrated	 before	
being	applied	to	6	mm	paper	disks	for	testing.	The	paper	
was	left	to	dry	and	for	the	solvent	to	evaporate	before	
being	used	in	the	antimicrobial	test.	The	sensitivity	of	
these	pathogenic	strains	to	the	extracted	fractions	was	
assessed	using	the	slightly	modified	Kirby	Bauer	Disk	
Diffusion	Susceptibility	method	(Bauer	et	al.,	1966).	
The	 diameter	 of	 the	 inhibition	 zone	 was	 measured	
in	 triplicate	and	 the	average	and	 standard	 deviation	
recorded	 (Table 4).	 Disks	 containing	 chloroform/
methanol	were	left	to	evaporate	and	were	then	used	as	
negative	controls.	
3. RESULTS
3.1. Morphological identification
Both	microalgal	strains	isolated	were	cocooid	cells	and	
were	either	solitary	or	aggregated	in	clumps	without	a	
common	sheath	around	them.	
3.2. Small subunit rRNA gene molecular analysis 
and phylogenetic reconstruction
The	 sequence	 retrieved	 was	 compared	 with	 other	
sequences	 deposited	 in	 GenBank	 using	 nucleotide	
BLAST	search.	The	sequence	showed	a	97%	similarity	
with	the	other	sequences,	with	the	best	relative	being	
Synechocystis  salina	 LEGE	 06099	 (HQ832895).	
The	 other	 best	 relatives	 were	 Synechocystis	
Synechocystis  salina	 LEGE	 06155	 (HQ832911),	
and	 Synechocystis	 PAK-12	 (EF429297),	 both	
showing	a	90%	similarity.	The	phylogenetic	analyses	
using	 different	 cyanobacterial	 representatives	 and	
employing	 different	 tree	 reconstruction	 methods	 all	
resulted	 in	 trees	 of	 similar	 topologies	 in	 which	 the	
isolate	clustered	with	Synechocystis.	They	showed	a	
distinct	clade	that	separated	away	from	the	out-group	
taxa	of	Microcystis	sp.	and	Lyngbya polychroa	LP16	
(FJ602745)	(Figure 1).	This	clade	was	supported	by	
a	91%	bootstrap	confidence	value.	The	Synechocystis	
clade	 including	 the	 strain	 under	 study	 was	 further	
sub-clustered	 from	 the	 main	 sub-clade	 containing	
Synechocystis	strains	with	a	relatively	large	bootstrap	
value	 (67%).	 The	 chrysophyte	 strain	 showed	 a	
97%	 similarity	 to	 Poterioochromonas  malhamensis	
(AB023070),	 followed	 by	 Poterioochromonas 
malhamensis	(FN662745),	and	Poterioochromonas	sp.	
Y8	(HM161748).	These	strains	formed	a	sub-cluster,	
supported	 by	 99%	 bootstrap	 values,	 from	 the	 rest	
of	 the	 Ochromonas	 strains	 and	 the	 out-group	 taxon	
Scenedesmus communis	(Figure 2).
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3.3. Antimicrobial bioassay
The	 preliminary	 antibiotic	 sensitivity	
tests	 showed	 the	 resistance	 of	 most	
of	 the	 pathogenic	 strains	 to	 the	 most	
commonly	 used	 antibiotics	 (Table 2).	
The	 only	 strain	 showing	 susceptibility	
to	 chloramphenicol	 and	 doxycycline	
was	 Streptococcus  faecalis.	 The	
lipophilic	 fractions	 of	 Aphanizomenon	
sp.	 did	 not	 show	 any	 antibacterial	
bioactivity	 against	 Citrobacter	 sp.,	
Escherichia	 coli,	 Proteus  mirabilis,	
Staphylococcus  epidermidis,	 MRSA	
Staphylococcus  aureus,	 Streptococccus	
faecalis,	 Klebsiella  pneumonia	 or	
Pseudomonas  aeruginosa.	 Fraction	V	
showed	 antifungal	 bioactivity	 against	
both	 Aspergillus  niger	 and	 Aspergillus 
flavus.	Fractions	IV	and	VI	showed	little	
antifungal	bioactivity	against	Aspergillus 
flavus	(Table 3).	The	lipophilic	fractions	
of	Synechocystis salina	were	not	effective	
against	Proteus mirabilis,	Staphylococcus 
epidermis,	MRSA	Staphylococcus aureus,	
Streptococccus  faecalis,	 Klebsiella 
pneumonia,	Pseudomonas aeruginosa	or	
the	pathogenic	fungus	Aspergillus flavus.	
The	 only	 fraction	 that	 was	 effective	
against	Aspergillus niger	was	fraction	V.	
Two	 fractions	 were	 effective	 against	
Citrobacter	 sp.	 (fractions	III	 and	 IV).	
These	fractions,	together	with	fraction	II,	
were	 effective	 against	 Salmonella  typhi	
(Table 3).	 The	 lipophilic	 fractions	 of	
67
68
96
91
Synechocystis sp. MMG-8
Synechocystis sp. PAK13
Synechocystis sp. PCC 6714
Synechocystis sp. PCC 6803
Synechocystis sp. PCC 6702
Synechocystis sp. SAI001
Microcystis aeruginosa PCC7806
Lyngbya polychroa LP16
Synechocystis aquatilis 1LT32S04
Synechocystis sp. PAK12
Synechocystis salina LEGE 06155
Synechocystis salina LEGE 06099
Synechocystis sp. aegyptiaca
Figure 1. Bootstrap-maximum	parsimony	tree	showing	the	clustering	of	
Synechocystis	strain	(arbitrarily	designated	as	Synechocystis	sp.	aegyptiaca).	
Lyngbya  polychroa	 LP16	 FJ602745).	 Synechocystis  salina	 LEGE	
06099	 (HQ832895).	 Synechocystis  aquatilis	 1LT	 32S04	 (FM177503).	
Synechocystis salina	LEGE	06155	(HQ832911).			Synechocystis	sp.	LMECYA	
68	 (EU078508).	 Synechocystis	 sp.	 PAK12	 (EF555570).	 Synechocystis	
sp.	 PCC	 6714	 (AB041937).	 Synechocystis	 sp.	 PAK13	 (EF555571).	
Synechocystis	sp.	LMECYA	68	(EU078508).	Synechocystis	sp.	PCC	6702	
(AB041936).	Synechocystis	sp.	PCC	6803	(AY224195).	Synechocystis	sp.	
PCC	6805	(AB041938).	Synechocystis	sp.	Sai001	(GU935367)	—	Arbre 
(dendrogramme) du bootstrap selon la méthode de maximum de parcimonie 
montrant le clustering de la souche Synechocystis (aléatoirement désignée 
par Synechocystis sp. aegyptiaca). Lyngbya	polychroa LP16 (FJ602745). 
Synechocystis	salina LEGE 06099 (HQ832895). Synechocystis	aquatilis 
1LT32S04 (FM177503). Synechocystis	salina	LEGE 06155 (HQ832911). 
Synechocystis  sp.  LMECYA  68  (EU078508).  Synechocystis  sp.  PAK12 
(EF555570).  Synechocystis  sp.  PCC  6714  (AB041937).  Synechocystis 
sp.  PAK13  (EF555571).  Synechocystis  sp.  LMECYA  68  (EU078508). 
Synechocystis sp. PCC 6702 (AB041936). Synechocystis sp. PCC 6803 
(AY224195). Synechocystis sp. PCC 6805 (AB041938). Synechocystis sp. 
Sai001 (GU935367).
Figure  2.	 Bootstrap-maximum	 parsimony	 tree	 showing	 the	 clustering	 of	 Ochromonas	 strains	 (arbitrarily	 designated	
as	 Poterioochromonas  malhamensis  aegyptiaca).	 Ochromonadaceae	 environmental	 sample	 clone	 Elev	 (EF024948).	
Ochromonas	cf.	gloeopara	strain	CCMP2060	(EF165113).	Poteriochromonas malhamensis	(AB023070).	Poterioochromonas	
malhamensis	 (FN662745).	 Poterioochromonas  malhamensis	 strain	 SAG933	 (EF165114).	 Poterioochromonas	 sp.	 DS	
(AM981258).	Poterioochromonas	sp.	Y8	(HM161748).	Poterioochromonas stipitata	(AF123295).	Scenedesmus communis	
(X73994)	—	Arbre (dendrogramme) du bootstrap selon la méthode de maximum de parcimonie montrant le clustering des 
souches Ochromonas (aléatoirement désignée par Poterioochromonas	malhamensis	aegyptiaca). Clone Ochromonadaceae 
d´echantillon environmental Elev (EF024948). Ochromonas cf. gloeopara souche CCMP2060 (EF165113). Poteriochromonas 
malhamensis (AB023070). Poterioochromonas	malhamensis (FN662745). Poterioochromonas	malhamensis souche SAG933 
(EF165114). Poterioochromonas sp. DS (AM981258). Poterioochromonas sp. Y8 (HM161748). Poterioochromonas	stipitata	
(AF123295). Scenedesmus	communis (X73994).
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57
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32
99
Ochromonas cf. gloeopara strain CCMP2760
Ochromonas cf. gloeopara strain CCMP2718
Poterioochromonas stipitata
Poterioochromonas sp. Y8
Poterioochromonas malhamensis
Poterioochromonas malhamensis AB023070
Poterioochromonas malhamensis aegyptiaca
Poterioochromonas sp. DS
Scenedesmus communis 18S
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Poterioochromonas  malhamensis	 were	 not	 effective	
against	any	fungal	strain	or	against	most	of	the	bacterial	
strains,	 except	 for	 Citrobacter	 sp.	 and	 Salmonella 
typhi.	Fractions	III.1	and	III.2	were	highly	effective	
against	these	last	two	bacterial	strains	(Table 4).
4. DISCUSSION
The	identity	of	the	local	microalgal	strains	(Synechocystis 
salina,	 a	 prokaryotic	 coccoid	 cyanobacterium	 and	
Poterioochromonas  malhamensis,	 a	 eukaryotic	
microalga	 belonging	 to	 the	 chrysophytes)	 was	
confirmed	 by	 traditional	 phenotypic	 characterization	
and	modern	molecular	and	phenotypic	analyses.	The	
high	percentage	of	sequence	identities	of	both	local	
strains	and	their	co-clustering	among	similar	isolates	
of	known	identities	further	confirmed	their	taxonomic	
designations.	 Poterioochromonas  malhamensis	 is	
known	 for	 its	 mixed	 mode	 of	 nutrition	 whereby	
phagotrophy	is	performed	in	the	form	of	bacteriovory	
along	with	phototrophy.	This	mixed	mode	of	nutrition	
is	very	important	in	aquatic	systems	as	it	ensures	the	
high	survival	rate	of	this	microalga	even	under	stress	
conditions.	It	also	means	that	high	death	rates	of	bacteria	
can	 be	 attributed	 to	 the	 activity	 of	 this	 microalga	
(Sanders	et	al.,	1990).	Supernatants	from	microalgal	
cultures	of	Poterioochromonas	malhamensis	have	been	
shown	to	exhibit	antibiotic	action	that	may	be	mostly	
attributed	to	lipophilic	substances	released	from	this	
microalga	 (Blom	 et	 al.,	 2010).	 In	 addition,	 extracts	
from	Poterioochromonas malhamensis	have	shown	a	
broad-spectrum	antibacterial	effect	(Blom	et	al.,	2010).	
Moreover,	 the	 bioactivity	 of	 one	 compound,	 called	
malhamensilipin	A,	isolated	from	this	microalga	has	
been	reported	(Pereira	et	al.,	2010).	Malhamensilipin	A	
acts	as	an	antiviral	and	antimicrobial	agent	as	well	as	
an	inhibitor	of	the	enzyme	tyrosine	kinase,	which	also	
indicates	its	possible	activity	as	an	anticancer	agent	
(Chen	et	al.,	1994).	The	microalga	Poterioochromonas	
malhamensis	 itself	 is	 reported	 to	 possess	 several	
chlorine-substituted	 bioactive	 compounds	 exhibiting	
antimicrobial	activity	(Chen	et	al.,	1994).	This	may	
explain	the	antimicrobial	bioactivity	of	extracts	from	
Table  3.  Antimicrobial	 activity	 of	 Aphanizomenon	 sp.	 and	 Synechocystis  salina	 against	 multidrug-resistant	
pathogens	—	Activité antimicrobienne de Aphanizomenon sp. et Synechocystis	salina contre des pathogènes résistants aux 
médicaments.
Solvent system 
Chloroform: 
methanol 
Cyanobacteria Fraction
(10	ml)
100:00 Aphanizomenon	
sp.	
I - - - - - - - - - - -
90:10 II - - - - - - - - - - -
80:20 III - - - - - - - - -
70:30 IV - 0.8	±	
(0.1)
- - - - - - - - 0.7	±	
(0.1)
60:40 V - - - - - - - - 1.1	±	
(0.1)
0.7	±	
(0.1)
50:50 VI - - - - - - - - - - 0.8	±	
(0.1)
100:0 Synechocystis 
salina
I - - - - - - - - - - -
90:10 II - 1.2	±	
(0.2)
- - - - - - - - -
80:20 III 1.0	±	
(0.2)
0.9	±	
(0.1)
- - - - - - - - -
70:30 IV - - - - - - - - - - -
60:40 V - - - - - - - - - 0.9	±	
(0.1)
-
50:50 VI 1.0	±	
(0.1)
0.8	±	
(0.1)
- - - - - - - - -
S:	Salmonella;	E:	Escherichia;	P:	Proteus;	S:	Staphylococcus;	S*:	Streptococcus;	K:	Klebsiella;	P:	Pseudomonas;	A:	Aspergillus.
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this	microalga	against	multidrug-resistant	strains	in	the	
present	study.
The	 second	 microalgal	 strain	 under	 study,	
Synechocystis  salina,	 was	 isolated	 from	 a	 highly-
polluted	 wastewater	 canal	 into	 which	 industrial,	
agricultural	 and	 domestic	 wastes	 are	 known	 to	 be	
released.	 This	 has	 resulted	 in	 water	 of	 a	 brackish	
nature	(conductivity	value	of	8,091	μS.cm-1)	(Hamed,	
2008)	and	the	prevalence	of	stressful	conditions	that	
select	for	microalgae	with	unique	metabolic	features,	
enabling	 them	 to	 survive	 and	 thrive	 (El	 Semary,	
2012).	 Interestingly,	 in	 his	 study	 of	 Egyptian	 water	
habitats,	including	water	bodies	in	the	Helwan	area,	
Hamed	(2008)	found	that	Synechocystis salina	thrived	
within	 the	 brackish-saline-hypersaline	 range	 of	
conductivity	in	a	wide	range	of	habitats.	This	indicates	
the	possibility	that	the	metabolic	adaptability	of	this	
cyanobacterium	is	mediated	through	the	possession	of	
unique	metabolites.	
Our	results	also	showed	the	extreme	resistance	of	
most	of	the	isolates	tested	to	the	most	commonly	used	
antibiotics.	 The	 emergence	 of	 microbial	 multidrug-
resistance	to	antibiotics	is	attributed	to	many	complex	
factors,	 such	 as	 mutations,	 genetic	 recombinations	
and	 geographical	 segregation	 (Hujer	 et	 al.,	 2006).	
Microbial	multidrug	resistance	represents	a	widespread	
problem	nowadays,	especially	where	antibiotics	have	
been	 intensively	 used	 (Piddock,	 2002).	 Pathogenic	
bacteria	 develop	 resistance	 by	 acquiring	 genes	 that	
encode	proteins	to	protect	them	from	the	effects	of	
the	antibiotic.	In	some	cases,	the	genes	arise	through	
mutation,	but	in	others	they	are	acquired	from	other	
bacteria	that	are	already	resistant	to	antibiotics.	These	
genes	are	often	found	on	plasmids,	which	spread	easily	
from	 one	 bacterium	 to	 another	 (Fluit	 et	 al.,	 2001;	
Bhakta	et	al.,	2003).
In	the	present	study,	although	extracts	were	relatively	
effective	 against	 some	 pathogens,	 no	 single	 extract	
had	a	broad-spectrum	effect	against	all	the	pathogenic	
strains	studied.	Nevertheless,	a	few	extracts	showed	
some	cross	antimicrobial	bioactivity	against	different	
microorganisms,	e.g.	fraction	IV	of	Aphanizomenon	sp.	
(Table 4).	El	Semary	(2009)	conducted	phytochemical	
screening	 for	 Aphanizomenon	 sp.,	 showing	 that	 the	
bacterium	possessed	alkaloids	and	flavonoids,	and	that	
it	had	a	relatively	high	lipid	content	as	well	as	a	high	
level	of	iron.	Interestingly,	in	the	same	study,	molecular	
screening	for	the	presence	of	genetic	loci	of	secondary	
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Table 4. Column	fractionation	and	the	antimicrobial	effect	of	the	lipophilic	extracts	from	the	microalga	Poterioochromonas 
malhamensis	 —	 Fractionnement  en  colonne  et  effet  antimicrobien  des  extraits  lipophiliques  de  la  microalgue 
Poterioochromonas	malhamensis.
Solvent system 
Chloroform: 
Methanol (v:v)
Fraction
100:00 I.1 - 1.1	±	
(0.1)
- - - - - - - - -
I.2 1.0	±	
(0.1)
0.8	±	
(0.1)
- - - - - - - - -
90:10 II.1 - - - - - - - - - - -
II.2 - - - - - - - - - - -
80:20 III.1 1.4	±	
(0.2)
1.4	±	
(0.2)
- - - - - - - - -
III.2 1.5	±	
(0.2)
1.1	±	
(0.2)
- - - - - - - - -
70:30 IV.1 - - - - - - - - - - -
IV.2 - 1.1	±	
(0.2)
- - - - - - - - -
60:40 V.1 1.1	±	
(0.1)
1.1	±	
(0.2)
- - - - - - - - -
V.2 - - - - - - - - - - -
-:	no	activity	—	pas d’activité;	S:	Salmonella;	E:	Escherichia;	P:	Proteus;	S:	Staphylococcus;	S*:	Streptococcus;	K:	Klebsiella;	P:	
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metabolites	 was	 positive	 for	 Aphanizomenon	 sp.,	
indicating	its	potentiality	as	a	producer	of	bioactive	
compounds	 and	 as	 a	 possible	 antibiotic	 resource.	
This	 hypothesis	 was	 then	 confirmed	 by	 the	 current	
investigation.
In	 conclusion,	 the	 extracts	 from	 the	 microalgae	
studied	 here	 showed	 considerable	 antimicrobial	
bioactivity	against	several	multidrug-resistant	isolates.	
Screening	 programs	 need	 to	 be	 extended	 further	 in	
order	 to	 discover	 more	 bioactive	 compounds	 from	
local	microalgal	strains	in	Egypt.
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